KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 170 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $875,892 | -25.9% | 653,650 | -1.1% | 0.00% | – |
| Q2 2023 | $1,182,503 | -33.1% | 660,616 | +45.4% | 0.00% | – |
| Q1 2023 | $1,767,873 | +20.1% | 454,466 | +5.0% | 0.00% | – |
| Q4 2022 | $1,471,796 | -9.8% | 432,881 | +44.8% | 0.00% | – |
| Q3 2022 | $1,632,000 | +26.4% | 298,991 | +4.4% | 0.00% | – |
| Q2 2022 | $1,291,000 | -41.0% | 286,381 | -3.5% | 0.00% | – |
| Q1 2022 | $2,188,000 | +14.4% | 296,900 | -0.2% | 0.00% | – |
| Q4 2021 | $1,913,000 | +8.7% | 297,541 | -1.6% | 0.00% | – |
| Q3 2021 | $1,760,000 | -41.0% | 302,501 | +4.7% | 0.00% | -100.0% |
| Q2 2021 | $2,983,000 | -11.4% | 289,056 | -9.6% | 0.00% | 0.0% |
| Q1 2021 | $3,365,000 | -33.9% | 319,758 | -2.8% | 0.00% | 0.0% |
| Q4 2020 | $5,093,000 | +0.7% | 328,960 | -5.1% | 0.00% | 0.0% |
| Q3 2020 | $5,059,000 | -16.5% | 346,513 | +8.3% | 0.00% | -50.0% |
| Q2 2020 | $6,062,000 | -3.6% | 320,014 | -2.3% | 0.00% | 0.0% |
| Q1 2020 | $6,291,000 | +12.7% | 327,439 | +12.5% | 0.00% | +100.0% |
| Q4 2019 | $5,580,000 | +141.3% | 291,093 | +21.1% | 0.00% | 0.0% |
| Q3 2019 | $2,312,000 | +66.6% | 240,287 | +3.7% | 0.00% | – |
| Q2 2019 | $1,388,000 | +8.5% | 231,640 | +5.8% | 0.00% | – |
| Q1 2019 | $1,279,000 | -37.5% | 218,978 | +0.3% | 0.00% | -100.0% |
| Q4 2018 | $2,047,000 | -45.0% | 218,412 | -0.1% | 0.00% | 0.0% |
| Q3 2018 | $3,723,000 | +2.4% | 218,594 | +2.1% | 0.00% | 0.0% |
| Q2 2018 | $3,636,000 | +62.1% | 214,018 | +28.1% | 0.00% | 0.0% |
| Q1 2018 | $2,243,000 | +43.2% | 167,107 | +2.5% | 0.00% | – |
| Q4 2017 | $1,566,000 | -13.0% | 163,093 | -0.4% | 0.00% | – |
| Q3 2017 | $1,799,000 | +22.2% | 163,810 | +0.7% | 0.00% | – |
| Q2 2017 | $1,472,000 | -36.9% | 162,678 | -10.4% | 0.00% | -100.0% |
| Q1 2017 | $2,332,000 | +120.8% | 181,602 | +61.7% | 0.00% | – |
| Q4 2016 | $1,056,000 | +23.7% | 112,287 | +27.9% | 0.00% | – |
| Q3 2016 | $854,000 | +25.2% | 87,806 | -13.5% | 0.00% | – |
| Q2 2016 | $682,000 | -21.5% | 101,558 | +4.3% | 0.00% | – |
| Q1 2016 | $869,000 | -37.1% | 97,385 | -6.6% | 0.00% | – |
| Q4 2015 | $1,382,000 | +25.6% | 104,297 | -0.2% | 0.00% | – |
| Q3 2015 | $1,100,000 | -64.3% | 104,506 | -7.8% | 0.00% | -100.0% |
| Q2 2015 | $3,083,000 | +24.1% | 113,305 | +39.6% | 0.00% | 0.0% |
| Q1 2015 | $2,484,000 | +5.3% | 81,144 | +28.7% | 0.00% | 0.0% |
| Q4 2014 | $2,359,000 | +7.4% | 63,025 | +0.2% | 0.00% | 0.0% |
| Q3 2014 | $2,197,000 | -50.3% | 62,885 | -33.8% | 0.00% | 0.0% |
| Q2 2014 | $4,420,000 | +161.1% | 94,946 | +73.2% | 0.00% | – |
| Q1 2014 | $1,693,000 | +174.4% | 54,809 | +103.4% | 0.00% | – |
| Q4 2013 | $617,000 | – | 26,941 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |